STAT+: FDA panel to weigh Grail’s Galleri test

Grail's Galleri test, a multi-cancer early detection blood test, is set to go before an FDA advisory panel. The panel will evaluate evidence on the test's performance and safety, and its recommendation will inform the FDA's regulatory decision.